The DMTN Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of Huh-7 cells with targeted disruption of the DMTN gene, encoding the actin-binding protein dematin. This pooled knockout model introduces loss-of-function mutations across the cell population, enabling the study of DMTN-dependent cellular functions without clonal selection pressures. The product is supplied as a mixed polyclonal pool, reflecting a range of editing events, and is suitable for applications requiring bulk population-level analysis of DMTN deficiency.
The host Huh-7 cell line is derived from a well-differentiated human hepatocellular carcinoma and retains many features of liver epithelial cells, including expression of hepatocyte markers and metabolic activity. This cell line is extensively used in virus replication studies, particularly for hepatitis C virus, as well as in drug metabolism and toxicity screening, and as a model system for hepatocellular carcinoma biology. Its epithelial nature and robust growth characteristics make it suitable for investigating cytoskeletal dynamics and cell adhesion pathways.
DMTN encodes an actin-bundling protein that crosslinks F-actin filaments and anchors them to the plasma membrane through interactions with spectrin, adducin, and tropomyosin. It is a downstream effector of Rho GTPase signaling and is transcriptionally regulated by serum response factor (SRF) and transforming growth factor-?? (TGF-??). DMTN organizes the cortical actin cytoskeleton and modulates cell shape, adhesion, and migration. At the molecular level, DMTN interfaces with the RhoA?CROCK?CLIMK?Ccofilin pathway, which controls actin dynamics; its depletion disrupts the balance between F-actin polymerization and severing, affecting cortactin-mediated actin assembly and focal adhesion turnover.
In the Huh-7 hepatocellular carcinoma background, DMTN knockout profoundly alters actin cytoskeleton architecture and membrane?Ccytoskeleton linkage. This disruption impairs cell adhesion and directional migration, two processes critical for tumor cell invasion and metastasis. Given the liver epithelial origin, this model provides insight into how actin-binding protein deficiencies affect hepatocyte-like cell behavior, including potential consequences for tissue organization and fibrotic responses. The knockout phenotype may also sensitize cells to mechanical stress or drugs targeting cytoskeletal integrity, offering a platform for mechanistic dissection of liver cancer progression.
A wide range of experimental approaches can be applied to this knockout model. Researchers can evaluate actin organization using phalloidin-based immunofluorescence, quantify migration defects via scratch wound and Transwell assays, and assess changes in protein interactions through co-immunoprecipitation of DMTN binding partners. Transcriptomic analysis by RNA-seq or RT-qPCR can reveal downstream gene expression alterations, while drug sensitivity profiling can test compounds targeting cytoskeletal pathways. The polyclonal nature allows observation of population-level responses. For additional technical specifications or to discuss custom modifications, please contact Ascent Research.
